Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Results 1 - 20 of 231 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar pchop12316 (77.40) Submitted: 7/17/2015 11:11:41 AM : Outperform Start Price: $68.95 BMY Score: -5.29

PE a little high but solid brand with one of the best pipelines of the big pharmas

Recs

0
Member Avatar jobronze (47.36) Submitted: 7/16/2015 12:42:20 AM : Outperform Start Price: $67.98 BMY Score: -4.64

Defensive, best pick in large cap Pharma. Decent yield, incredible pipeline and new found growth focus as bio specialty

Recs

0
Member Avatar SapphireSeas (72.45) Submitted: 6/1/2015 2:29:55 PM : Outperform Start Price: $66.31 BMY Score: -1.46

A leader in cardiovascular R&D and treatments, and now coming on strong with two immunotherapy candidates - ipilimumab and nivolumab - which show tremendous promise.

Recs

0
Member Avatar andrewtraylor (76.26) Submitted: 5/8/2015 6:39:40 PM : Outperform Start Price: $66.62 BMY Score: -2.22

M.I.T.B.- Money in the Bank

Recs

0
Member Avatar hutchcraft2 (55.70) Submitted: 3/18/2015 4:32:47 PM : Outperform Start Price: $67.60 BMY Score: -4.40

Well managed with strong product line.

Recs

0
Member Avatar Defshark82 (79.90) Submitted: 12/31/2014 11:44:21 AM : Outperform Start Price: $59.11 BMY Score: +8.42

Tracking JPM top pick

Recs

0
Member Avatar foolmelgoner (85.66) Submitted: 12/15/2014 8:49:32 PM : Outperform Start Price: $57.29 BMY Score: +7.13

Solid pipeline, good management

Recs

0
Member Avatar AnsgarJohn (98.39) Submitted: 11/16/2014 8:54:06 AM : Underperform Start Price: $56.73 BMY Score: -10.99

Bristol-Myers a favorite of Jima Cramer and Fools, but seems to be getting ahead of itself. PE almost 40, not much growth. End ASAP http://www.gurufocus.com/stock/BMY&summary

Recs

0
Member Avatar mrgekko (61.33) Submitted: 11/7/2014 4:56:31 AM : Outperform Start Price: $57.25 BMY Score: +9.61

some great phase 3 drugs and in the right areas

Recs

0
Member Avatar JeffRossMD (< 20) Submitted: 10/30/2014 12:44:24 PM : Outperform Start Price: $57.25 BMY Score: +7.38

The biotech space is just heating up as new technologies are revolutionizing cancer and chronic disease processes.

Recs

0
Member Avatar mikeayu (< 20) Submitted: 10/14/2014 7:06:01 PM : Outperform Start Price: $47.52 BMY Score: +22.72

Huge upside from cancel drugs.

Recs

0
Member Avatar afewgoodstocks14 (< 20) Submitted: 10/1/2014 2:23:35 PM : Outperform Start Price: $49.64 BMY Score: +18.80

Div. (Yield) $1.44 (2.8%)

Recs

0
Member Avatar Herbstmd (59.26) Submitted: 8/22/2014 11:55:42 AM : Outperform Start Price: $48.82 BMY Score: +27.16

Developing great new cancer drugs called PD1, which may revolutionize cancer therapy.

Recs

0
Member Avatar Kenji94 (48.35) Submitted: 8/19/2014 1:29:19 AM : Underperform Start Price: $48.94 BMY Score: -26.04

There is a disconnection between price and fundamentals. I would like to own the company, but not at this price.

Recs

0
Member Avatar hydn (< 20) Submitted: 5/16/2014 10:28:57 AM : Outperform Start Price: $47.25 BMY Score: +24.64

Solid demand for ever improving products.

Recs

0
Member Avatar Johnybe (62.21) Submitted: 5/14/2014 9:46:28 PM : Outperform Start Price: $47.95 BMY Score: +23.60

strong player in this sector

Recs

0
Member Avatar DRGRNR (< 20) Submitted: 4/15/2014 7:52:17 PM : Outperform Start Price: $46.90 BMY Score: +24.72

I've owned BMY for 30 years, always a strong performer.

Recs

0
Member Avatar bassnman45 (36.44) Submitted: 1/2/2014 9:30:25 PM : Outperform Start Price: $20.50 BMY Score: +143.54

buy, hold long term and monitor

Recs

1
Member Avatar johnclanaro (< 20) Submitted: 10/28/2013 3:54:27 PM : Outperform Start Price: $49.80 BMY Score: +10.69

recent upgrade. good pipeline.

Recs

1
Member Avatar gilmomp1 (62.87) Submitted: 10/16/2013 9:38:21 PM : Outperform Start Price: $46.41 BMY Score: +16.82

I bought 100 shares of this company pre 1995 and now own 188 shares by reinvesting my dividends. Now that I'm nearing retirement that dividend looks pretty good!

Featured Broker Partners


Advertisement